Lyell Immunopharma
LYEL
LYEL
62 hedge funds and large institutions have $1.22B invested in Lyell Immunopharma in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less capital invested
Capital invested by funds: $1.29B → $1.22B (-$72.7M)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
62
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$17.5M | |
| 2 | +$17.2M | |
| 3 | +$9.02M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.86M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$6.76M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$8.85M | |
| 3 | -$4.35M | |
| 4 |
Goldman Sachs
New York
|
-$3.28M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.6M |